Quick Answer
Prime Medicine, Inc. reported Operating Income of -$208.35 million for fiscal year 2025.
Prime Medicine, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$208.35M | -2.9% |
| 2024 | -$202.47M | +1.1% |
| 2023 | -$204.79M | -75.7% |
| 2022 | -$116.54M | -38.0% |
| 2021 | -$84.47M | -8963.7% |
| 2020 | -$932.0K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$53.97M | +0.5% | -1.1% |
| June 30, 2025 | -$53.38M | +4.1% | -1.9% |
| March 31, 2025 | -$52.39M | -8.4% | +3.4% |
| September 30, 2024 | -$54.23M | -5.4% | +2.6% |
| June 30, 2024 | -$55.67M | -23.0% | -15.2% |
| March 31, 2024 | -$48.34M | -20.8% | +6.1% |
| September 30, 2023 | -$51.46M | -62.6% | -13.7% |
| June 30, 2023 | -$45.26M | -72.0% | -13.0% |
- Prime Medicine, Inc. showed a decrease of -2.9% in Operating Income compared to the prior fiscal year.
- Over the 2020–2025 period, Prime Medicine, Inc.’s operating income has declined by 22255.2% (from -$932.0 thousand to -$208.35 million).
- The most recent figure is from Prime Medicine, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: